Evidence map›Paper›PMID 31338197›Full record

ReviewPharmacology research & perspectives2019

Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.

Frederik N Ågesen, Peter E Weeke, Peer Tfelt-Hansen, Jacob Tfelt-Hansen, for ESCAPE‐NET

Registry-linked trialAbstract readReview
In one paragraph

Review in Pharmacology research & perspectives, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05536271 (Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05536271 phase2completednot on this mapstarted 2021, after this paper: background citation

Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome

TypeinterventionalSponsorDamanhour UniversityRan2021 to 2022Enrolled127ConditionsAcute Coronary SyndromeArmsBisoprolol Fumarate
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Target the Heart: A New Axis of Alzheimer's Disease Prevention.Journal of dementia and alzheimer's disease · 2025
    Article
  10. Bioadhesive Eudragit RLPharmaceutics · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frederik N ÅgesenDepartment of Cardiology University of Copenhagen Rigshospitalet, Copenhagen Denmark.ORCID 0000-0003-1572-7977
Peter E WeekeDepartment of Cardiology University of Copenhagen Rigshospitalet, Copenhagen Denmark.
Peer Tfelt-HansenDanish Headache Center, Department of Neurology University of Copenhagen, Rigshospitalet-Glostrup Hospital Glostrup Denmark.
Jacob Tfelt-HansenDepartment of Cardiology University of Copenhagen Rigshospitalet, Copenhagen Denmark.
for ESCAPE‐NET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology by reviewing single-dose and steady-state pharmacokinetic studies from the literature. PubMed was searched for pharmacokinetic studies of beta-adrenergic blocking agents, both single-dose and steady-state studies. The studies included reported maximum plasma concentration (C

Indexed as

Adrenergic beta-AntagonistsArea Under CurveBiological AvailabilityCarvedilolHealthy VolunteersHumansMaleMetoprololPropranololAdrenergic beta-AntagonistsCarvedilolMetoprololPropranololbeta‐adrenergic blocking agentsmetoprololpersonalized medicinePharmacokineticspharmacologypropranolol

Identifiers

PMID31338197
PMCPMC6624454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.